First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) Short Interest Update

First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) was the recipient of a significant increase in short interest in August. As of August 31st, there was short interest totalling 900 shares, an increase of 200.0% from the August 15th total of 300 shares. Based on an average daily trading volume, of 6,000 shares, the short-interest ratio is presently 0.2 days.

First Trust Nasdaq Pharmaceuticals ETF Stock Performance

Shares of NASDAQ FTXH traded up $0.20 during mid-day trading on Friday, hitting $29.19. 1,391 shares of the stock were exchanged, compared to its average volume of 5,876. First Trust Nasdaq Pharmaceuticals ETF has a twelve month low of $23.85 and a twelve month high of $29.72. The stock’s fifty day simple moving average is $28.65 and its two-hundred day simple moving average is $27.61. The company has a market cap of $18.97 million, a P/E ratio of 15.98 and a beta of 0.70.

First Trust Nasdaq Pharmaceuticals ETF Increases Dividend

The business also recently declared a dividend, which was paid on Friday, June 28th. Stockholders of record on Thursday, June 27th were paid a dividend of $0.1284 per share. This is a boost from First Trust Nasdaq Pharmaceuticals ETF’s previous dividend of $0.07. The ex-dividend date of this dividend was Thursday, June 27th.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of the stock. International Assets Investment Management LLC bought a new stake in shares of First Trust Nasdaq Pharmaceuticals ETF during the second quarter worth $73,000. Ameritas Investment Partners Inc. increased its position in First Trust Nasdaq Pharmaceuticals ETF by 5.5% in the first quarter. Ameritas Investment Partners Inc. now owns 11,200 shares of the company’s stock worth $314,000 after purchasing an additional 587 shares during the period. Finally, Janney Montgomery Scott LLC bought a new stake in First Trust Nasdaq Pharmaceuticals ETF during the 1st quarter worth about $1,030,000.

About First Trust Nasdaq Pharmaceuticals ETF

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.